Inspired Healthcare on Tuesday asked a Texas bankruptcy judge to approve the sale of 30 of its senior living communities but to leave for later the question of how the $713 million in proceeds will be split am... (more story)

Sanofi's patent infringement suit against Moderna is an attempt to "unjustly profit" from the latter's COVID-19 vaccines after Sanofi was unable to produce its own, Moderna has told a New Jersey federal court.

Fitness-tracking ring maker Oura on Monday unveiled a target price range for its public debut, telling the U.S. Securities and Exchange Commission that it plans to raise roughly $2.1 billion.

Eli Lilly & Co. turned Nektar Therapeutics' autoimmune-disease drug Rezpeg into "damaged goods" by breaching the companies' co-development deal and delaying the medication's development in favor of a competing... (more story)

Cooley LLP-advised Electra Therapeutics, a venture-backed biotech firm developing antibodies for immune diseases and cancer, began trading Friday after raising $350 million in an upsized IPO.

A Massachusetts federal judge denied investors another chance to rework their suit accusing Sarepta Therapeutics and its executives of misleading the market about the safety and efficacy of their muscular dyst... (more story)

A California federal judge ordered Meta on Tuesday to rereview privilege designations on 300 documents in social media addiction litigation, after plaintiffs' lawyers cited a "culture of privilege abuse" epito... (more story)

New Jersey's attorney general urged a state court Friday to find TikTok liable for operating an unlicensed money transmission business via its livestreaming service, arguing the platform receives users' money,... (more story)

A New York federal judge dismissed a proposed class action alleging IBM and Johnson & Johnson's healthcare arm failed to safeguard sensitive health information of thousands of patients before a 2023 data breac... (more story)

A healthcare consulting services company wants the U.S. Supreme Court to review the Federal Circuit's refusal to revive its copyright and contract claims in a fight over rights to healthcare software for a U.S... (more story)

The full U.S. International Trade Commission is set to look at parts of an agency judge's ruling in favor of medical technology company Stryker Corp. in a fight against imports it said infringed its patents on... (more story)

A new data-sharing deal between federal drug and securities officials means drugmakers better have their story straight when they tell investors and the public about U.S. Food and Drug Administration approvals.

Law360 Healthcare Authority looks at a First Circuit decision backing criminal penalties on a psychiatrist convicted for submitting $19 million in fraudulent claims, the Second Circuit's conclusion that the No... (more story)

A Georgia federal judge vacated the Food and Drug Administration's classification of biomedical company MiMedx's wound care treatment as a biological product, which carries heightened regulatory requirements, ... (more story)

New York and other states applauded a Rhode Island federal judge's finding that the Trump administration flouted rulemaking requirements when it reinterpreted a 30-year-old welfare reform bill to try to subjec... (more story)

The Trump administration on Tuesday said it's kicking about 760,000 enrollees off the Affordable Care Act insurance marketplace, saying they aren't eligible for subsidies or don't exist at all.

Dialysis company Fresenius has agreed to resolve a proposed class action accusing it of unlawfully using forfeited 401(k) funds to cover its obligations to the plan rather than pay for the plan's administrativ... (more story)

Patient and consumer choice are crucial to driving down healthcare costs, while overregulation tends to increase insurance costs and Medicare spending, the chief economist and regulatory officer of the U.S. De... (more story)